Free Trial
TSE:GEN

GeneNews (GEN) Stock Price, News & Analysis

GeneNews logo

About GeneNews Stock (TSE:GEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
473,147 shs
Average Volume
1.48 million shs
Market Capitalization
C$25.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Generation Uranium Inc. engages in the exploration and development of mineral properties. It has an option agreement to acquire a 60% interest in the Arlington property that comprises five mineral claims located in the Arrow Boundary District of south-central British Columbia, Canada; and holds a 100% interest in the YATH Uranium Property comprises five mineral claims that totaling approximately 8,438 hectares located in the territory of Nunavut. The company was formerly known as Generation Gold Corp. and changed its name to Generation Uranium Inc. in January 30, 2024. Generation Uranium Inc. was incorporated in 2018 and is based in Vancouver, Canada.

Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeneNews and its competitors with MarketBeat's FREE daily newsletter.

GEN Stock News Headlines

GeneNews: Q1 Earnings Snapshot
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Headlines

GEN Stock Analysis - Frequently Asked Questions

Shares of GEN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that GeneNews investors own include MARA (MARA), Ocugen (OCGN), Spero Therapeutics (SPRO), American Airlines Group (AAL), First Majestic Silver (AG) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Computer Software
Current Symbol
TSE:GEN
CIK
N/A
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$234,592.00
Price / Cash Flow
145.00
Book Value
C($0.06) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$25.49 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (TSE:GEN) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners